SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Xue Qin Yu, Qingwei Luo, David P. Smith, Mark S. Clements, Dianne L. O’Connell, Prostate cancer prevalence in New South Wales Australia: A population-based study, Cancer Epidemiology, 2015, 39, 1, 29

    CrossRef

  2. 2
    Simon Crouch, Alex Smith, Dan Painter, Jinlei Li, Eve Roman, Determining disease prevalence from incidence and survival using simulation techniques, Cancer Epidemiology, 2014, 38, 2, 193

    CrossRef

  3. 3
    Linda Sharp, Sandra Deady, Pamela Gallagher, Michal Molcho, Alison Pearce, Audrey Alforque Thomas, Aileen Timmons, Harry Comber, The magnitude and characteristics of the population of cancer survivors: using population-based estimates of cancer prevalence to inform service planning for survivorship care, BMC Cancer, 2014, 14, 1, 767

    CrossRef

  4. 4
    Pär Parén, Maria Schaufelberger, Lena Björck, Georgios Lappas, Michael Fu, Annika Rosengren, Trends in prevalence from 1990 to 2007 of patients hospitalized with heart failure in Sweden, European Journal of Heart Failure, 2014, 16, 7
  5. 5
    Silvia Francisci, Stefano Guzzinati, Maura Mezzetti, Emanuele Crocetti, Francesco Giusti, Guido Miccinesi, Eugenio Paci, Catia Angiolini, Anna Gigli, Cost profiles of colorectal cancer patients in Italy based on individual patterns of care, BMC Cancer, 2013, 13, 1, 329

    CrossRef

  6. 6
    Sandra Mallone, Roberta De Angelis, Jan Maarten van der Zwan, Annalisa Trama, Sabine Siesling, Gemma Gatta, Riccardo Capocaccia, Methodological aspects of estimating rare cancer prevalence in Europe: The experience of the RARECARE project, Cancer Epidemiology, 2013, 37, 6, 850

    CrossRef

  7. 7
    Xue Qin Yu, Mark Clements, Dianne O’Connell, Projections of cancer prevalence by phase of care: a potential tool for planning future health service needs, Journal of Cancer Survivorship, 2013, 7, 4, 641

    CrossRef

  8. 8
    Mark S. Clements, David M. Roder, Xue Qin Yu, Sam Egger, Dianne L. O’Connell, Estimating prevalence of distant metastatic breast cancer: a means of filling a data gap, Cancer Causes & Control, 2012, 23, 10, 1625

    CrossRef

  9. 9
    Barry Kurt Moser, Susan Halabi, Estimation and testing of the relative risk of disease in case-control studies with a set of k matched controls per case with known prevalence of disease , Statistics in Medicine, 2012, 31, 1
  10. 10
    Andres Pichon-Riviere, Federico Augustovski, Ariel Bardach, Lisandro Colantonio, Development and Validation of a Microsimulation Economic Model to Evaluate the Disease Burden Associated with Smoking and the Cost-Effectiveness of Tobacco Control Interventions in Latin America, Value in Health, 2011, 14, 5, S51

    CrossRef

  11. 11
    Jun Yan, Yu Cheng, Jason P. Fine, HuiChuan J. Lai, Uncovering Symptom Progression History from Disease Registry Data with Application to Young Cystic Fibrosis Patients, Biometrics, 2010, 66, 2
  12. 12
    Arianna Simonetti, Anna Gigli, Riccardo Capocaccia, Angela Mariotto, Estimating complete prevalence of cancers diagnosed in childhood, Statistics in Medicine, 2008, 27, 7
  13. 13
    Toni P. Miles, Correctable Sources of Disparities in Cancer Among Minority Elders, Medical Clinics of North America, 2005, 89, 4, 869

    CrossRef

  14. 14
    Norman Phillips, Andrew Coldman, Mary L. McBride, Estimating cancer prevalence using mixture models for cancer survival, Statistics in Medicine, 2002, 21, 9
  15. 15
    Limin X. Clegg, Mitchell H. Gail, Eric J. Feuer, Estimating the Variance of Disease-Prevalence Estimates from Population-Based Registries, Biometrics, 2002, 58, 3
  16. 16
    R. Capocaccia, M. Colonna, I. Corazziari, R. De Angelis, S. Francisci, A. Micheli, E. Mugno, Measuring cancer prevalence in Europe: the EUROPREVAL Project, Annals of Oncology, 2002, 13, 6, 831

    CrossRef

  17. 17
    Eve Mathieu-Dupas, Claudine Gras-Aygon, Jean-Pierre Daurès, Semi-Markov Processes and Usefulness in Medicine,